Industry Research Reports
Home > Reports > Medical Devices & Consumables > Autologous Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Autologous Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 97 Pages
Report ld: 3496943
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Autologous Biologics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
North American market for Autologous Biologics was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Autologous Biologics was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Autologous Biologics was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Autologous Biologics include Vericel Corporation, BioTime, Inc., Pharmicell Co., BrainStorm Cell Therapeutics, Opexa Therapeutics, Inc, Pharmicell Co., Inc, Neostem, Dendreon Corporation, Regenexx, Cytori Therapeutics, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Autologous Biologics, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Autologous Biologics by region & country, by Type, and by Application.
The Autologous Biologics market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autologous Biologics.
MARKET SEGMENTATION
By Company
- Vericel Corporation
- BioTime, Inc.
- Pharmicell Co.
- BrainStorm Cell Therapeutics
- Opexa Therapeutics, Inc
- Pharmicell Co., Inc
- Neostem
- Dendreon Corporation
- Regenexx
- Cytori Therapeutics
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Adipose Tissue
- Plasma
- Others
Segment by Application
- Hospitals
- Ambulatory Centers
- Research Centers
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Autologous Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Autologous Biologics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Autologous Biologics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Autologous Biologics Product Introduction
1.2 Global Autologous Biologics Market Size Forecast
1.2.1 Global Autologous Biologics Sales Value (2020-2031)
1.2.2 Global Autologous Biologics Sales Volume (2020-2031)
1.2.3 Global Autologous Biologics Sales Price (2020-2031)
1.3 Autologous Biologics Market Trends & Drivers
1.3.1 Autologous Biologics Industry Trends
1.3.2 Autologous Biologics Market Drivers & Opportunity
1.3.3 Autologous Biologics Market Challenges
1.3.4 Autologous Biologics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Autologous Biologics Players Revenue Ranking (2024)
2.2 Global Autologous Biologics Revenue by Company (2020-2025)
2.3 Global Autologous Biologics Players Sales Volume Ranking (2024)
2.4 Global Autologous Biologics Sales Volume by Company Players (2020-2025)
2.5 Global Autologous Biologics Average Price by Company (2020-2025)
2.6 Key Manufacturers Autologous Biologics Manufacturing Base and Headquarters
2.7 Key Manufacturers Autologous Biologics Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Autologous Biologics
2.9 Autologous Biologics Market Competitive Analysis
2.9.1 Autologous Biologics Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Autologous Biologics Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Biologics as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Adipose Tissue
3.1.2 Plasma
3.1.3 Others
3.2 Global Autologous Biologics Sales Value by Type
3.2.1 Global Autologous Biologics Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Autologous Biologics Sales Value, by Type (2020-2031)
3.2.3 Global Autologous Biologics Sales Value, by Type (%) (2020-2031)
3.3 Global Autologous Biologics Sales Volume by Type
3.3.1 Global Autologous Biologics Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Autologous Biologics Sales Volume, by Type (2020-2031)
3.3.3 Global Autologous Biologics Sales Volume, by Type (%) (2020-2031)
3.4 Global Autologous Biologics Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Ambulatory Centers
4.1.3 Research Centers
4.2 Global Autologous Biologics Sales Value by Application
4.2.1 Global Autologous Biologics Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Autologous Biologics Sales Value, by Application (2020-2031)
4.2.3 Global Autologous Biologics Sales Value, by Application (%) (2020-2031)
4.3 Global Autologous Biologics Sales Volume by Application
4.3.1 Global Autologous Biologics Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Autologous Biologics Sales Volume, by Application (2020-2031)
4.3.3 Global Autologous Biologics Sales Volume, by Application (%) (2020-2031)
4.4 Global Autologous Biologics Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Autologous Biologics Sales Value by Region
5.1.1 Global Autologous Biologics Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Autologous Biologics Sales Value by Region (2020-2025)
5.1.3 Global Autologous Biologics Sales Value by Region (2026-2031)
5.1.4 Global Autologous Biologics Sales Value by Region (%), (2020-2031)
5.2 Global Autologous Biologics Sales Volume by Region
5.2.1 Global Autologous Biologics Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Autologous Biologics Sales Volume by Region (2020-2025)
5.2.3 Global Autologous Biologics Sales Volume by Region (2026-2031)
5.2.4 Global Autologous Biologics Sales Volume by Region (%), (2020-2031)
5.3 Global Autologous Biologics Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Autologous Biologics Sales Value, 2020-2031
5.4.2 North America Autologous Biologics Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Autologous Biologics Sales Value, 2020-2031
5.5.2 Europe Autologous Biologics Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Autologous Biologics Sales Value, 2020-2031
5.6.2 Asia Pacific Autologous Biologics Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Autologous Biologics Sales Value, 2020-2031
5.7.2 South America Autologous Biologics Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Autologous Biologics Sales Value, 2020-2031
5.8.2 Middle East & Africa Autologous Biologics Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Autologous Biologics Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Autologous Biologics Sales Value
6.2.1 Key Countries/Regions Autologous Biologics Sales Value, 2020-2031
6.2.2 Key Countries/Regions Autologous Biologics Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Autologous Biologics Sales Value, 2020-2031
6.3.2 United States Autologous Biologics Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Autologous Biologics Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Autologous Biologics Sales Value, 2020-2031
6.4.2 Europe Autologous Biologics Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Autologous Biologics Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Autologous Biologics Sales Value, 2020-2031
6.5.2 China Autologous Biologics Sales Value by Type (%), 2024 VS 2031
6.5.3 China Autologous Biologics Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Autologous Biologics Sales Value, 2020-2031
6.6.2 Japan Autologous Biologics Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Autologous Biologics Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Autologous Biologics Sales Value, 2020-2031
6.7.2 South Korea Autologous Biologics Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Autologous Biologics Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Autologous Biologics Sales Value, 2020-2031
6.8.2 Southeast Asia Autologous Biologics Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Autologous Biologics Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Autologous Biologics Sales Value, 2020-2031
6.9.2 India Autologous Biologics Sales Value by Type (%), 2024 VS 2031
6.9.3 India Autologous Biologics Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Vericel Corporation
7.1.1 Vericel Corporation Company Information
7.1.2 Vericel Corporation Introduction and Business Overview
7.1.3 Vericel Corporation Autologous Biologics Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Vericel Corporation Autologous Biologics Product Offerings
7.1.5 Vericel Corporation Recent Development
7.2 BioTime, Inc.
7.2.1 BioTime, Inc. Company Information
7.2.2 BioTime, Inc. Introduction and Business Overview
7.2.3 BioTime, Inc. Autologous Biologics Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 BioTime, Inc. Autologous Biologics Product Offerings
7.2.5 BioTime, Inc. Recent Development
7.3 Pharmicell Co.
7.3.1 Pharmicell Co. Company Information
7.3.2 Pharmicell Co. Introduction and Business Overview
7.3.3 Pharmicell Co. Autologous Biologics Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Pharmicell Co. Autologous Biologics Product Offerings
7.3.5 Pharmicell Co. Recent Development
7.4 BrainStorm Cell Therapeutics
7.4.1 BrainStorm Cell Therapeutics Company Information
7.4.2 BrainStorm Cell Therapeutics Introduction and Business Overview
7.4.3 BrainStorm Cell Therapeutics Autologous Biologics Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 BrainStorm Cell Therapeutics Autologous Biologics Product Offerings
7.4.5 BrainStorm Cell Therapeutics Recent Development
7.5 Opexa Therapeutics, Inc
7.5.1 Opexa Therapeutics, Inc Company Information
7.5.2 Opexa Therapeutics, Inc Introduction and Business Overview
7.5.3 Opexa Therapeutics, Inc Autologous Biologics Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Opexa Therapeutics, Inc Autologous Biologics Product Offerings
7.5.5 Opexa Therapeutics, Inc Recent Development
7.6 Pharmicell Co., Inc
7.6.1 Pharmicell Co., Inc Company Information
7.6.2 Pharmicell Co., Inc Introduction and Business Overview
7.6.3 Pharmicell Co., Inc Autologous Biologics Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Pharmicell Co., Inc Autologous Biologics Product Offerings
7.6.5 Pharmicell Co., Inc Recent Development
7.7 Neostem
7.7.1 Neostem Company Information
7.7.2 Neostem Introduction and Business Overview
7.7.3 Neostem Autologous Biologics Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Neostem Autologous Biologics Product Offerings
7.7.5 Neostem Recent Development
7.8 Dendreon Corporation
7.8.1 Dendreon Corporation Company Information
7.8.2 Dendreon Corporation Introduction and Business Overview
7.8.3 Dendreon Corporation Autologous Biologics Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Dendreon Corporation Autologous Biologics Product Offerings
7.8.5 Dendreon Corporation Recent Development
7.9 Regenexx
7.9.1 Regenexx Company Information
7.9.2 Regenexx Introduction and Business Overview
7.9.3 Regenexx Autologous Biologics Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Regenexx Autologous Biologics Product Offerings
7.9.5 Regenexx Recent Development
7.10 Cytori Therapeutics
7.10.1 Cytori Therapeutics Company Information
7.10.2 Cytori Therapeutics Introduction and Business Overview
7.10.3 Cytori Therapeutics Autologous Biologics Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Cytori Therapeutics Autologous Biologics Product Offerings
7.10.5 Cytori Therapeutics Recent Development
8 Industry Chain Analysis
8.1 Autologous Biologics Industrial Chain
8.2 Autologous Biologics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Autologous Biologics Sales Model
8.5.2 Sales Channel
8.5.3 Autologous Biologics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Autologous Biologics Market Trends
Table 2. Autologous Biologics Market Drivers & Opportunity
Table 3. Autologous Biologics Market Challenges
Table 4. Autologous Biologics Market Restraints
Table 5. Global Autologous Biologics Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Autologous Biologics Revenue Market Share by Company (2020-2025)
Table 7. Global Autologous Biologics Sales Volume by Company (2020-2025) & (Kg)
Table 8. Global Autologous Biologics Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Autologous Biologics Price by Company (2020-2025) & (US$/Kg)
Table 10. Key Manufacturers Autologous Biologics Manufacturing Base and Headquarters
Table 11. Key Manufacturers Autologous Biologics Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Autologous Biologics
Table 13. Global Autologous Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Biologics as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Autologous Biologics Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Autologous Biologics Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Autologous Biologics Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Autologous Biologics Sales Market Share in Value by Type (2020-2025)
Table 20. Global Autologous Biologics Sales Market Share in Value by Type (2026-2031)
Table 21. Global Autologous Biologics Sales Volume by Type: 2020 VS 2024 VS 2031 (Kg)
Table 22. Global Autologous Biologics Sales Volume by Type (2020-2025) & (Kg)
Table 23. Global Autologous Biologics Sales Volume by Type (2026-2031) & (Kg)
Table 24. Global Autologous Biologics Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Autologous Biologics Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Autologous Biologics Price by Type (2020-2025) & (US$/Kg)
Table 27. Global Autologous Biologics Price by Type (2026-2031) & (US$/Kg)
Table 28. Global Autologous Biologics Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Autologous Biologics Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Autologous Biologics Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Autologous Biologics Sales Market Share in Value by Application (2020-2025)
Table 32. Global Autologous Biologics Sales Market Share in Value by Application (2026-2031)
Table 33. Global Autologous Biologics Sales Volume by Application: 2020 VS 2024 VS 2031 (Kg)
Table 34. Global Autologous Biologics Sales Volume by Application (2020-2025) & (Kg)
Table 35. Global Autologous Biologics Sales Volume by Application (2026-2031) & (Kg)
Table 36. Global Autologous Biologics Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Autologous Biologics Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Autologous Biologics Price by Application (2020-2025) & (US$/Kg)
Table 39. Global Autologous Biologics Price by Application (2026-2031) & (US$/Kg)
Table 40. Global Autologous Biologics Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Autologous Biologics Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Autologous Biologics Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Autologous Biologics Sales Value by Region (2020-2025) & (%)
Table 44. Global Autologous Biologics Sales Value by Region (2026-2031) & (%)
Table 45. Global Autologous Biologics Sales Volume by Region (Kg): 2020 VS 2024 VS 2031
Table 46. Global Autologous Biologics Sales Volume by Region (2020-2025) & (Kg)
Table 47. Global Autologous Biologics Sales Volume by Region (2026-2031) & (Kg)
Table 48. Global Autologous Biologics Sales Volume by Region (2020-2025) & (%)
Table 49. Global Autologous Biologics Sales Volume by Region (2026-2031) & (%)
Table 50. Global Autologous Biologics Average Price by Region (2020-2025) & (US$/Kg)
Table 51. Global Autologous Biologics Average Price by Region (2026-2031) & (US$/Kg)
Table 52. Key Countries/Regions Autologous Biologics Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Autologous Biologics Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Autologous Biologics Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Autologous Biologics Sales Volume, (2020-2025) & (Kg)
Table 56. Key Countries/Regions Autologous Biologics Sales Volume, (2026-2031) & (Kg)
Table 57. Vericel Corporation Company Information
Table 58. Vericel Corporation Introduction and Business Overview
Table 59. Vericel Corporation Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 60. Vericel Corporation Autologous Biologics Product Offerings
Table 61. Vericel Corporation Recent Development
Table 62. BioTime, Inc. Company Information
Table 63. BioTime, Inc. Introduction and Business Overview
Table 64. BioTime, Inc. Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 65. BioTime, Inc. Autologous Biologics Product Offerings
Table 66. BioTime, Inc. Recent Development
Table 67. Pharmicell Co. Company Information
Table 68. Pharmicell Co. Introduction and Business Overview
Table 69. Pharmicell Co. Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 70. Pharmicell Co. Autologous Biologics Product Offerings
Table 71. Pharmicell Co. Recent Development
Table 72. BrainStorm Cell Therapeutics Company Information
Table 73. BrainStorm Cell Therapeutics Introduction and Business Overview
Table 74. BrainStorm Cell Therapeutics Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 75. BrainStorm Cell Therapeutics Autologous Biologics Product Offerings
Table 76. BrainStorm Cell Therapeutics Recent Development
Table 77. Opexa Therapeutics, Inc Company Information
Table 78. Opexa Therapeutics, Inc Introduction and Business Overview
Table 79. Opexa Therapeutics, Inc Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 80. Opexa Therapeutics, Inc Autologous Biologics Product Offerings
Table 81. Opexa Therapeutics, Inc Recent Development
Table 82. Pharmicell Co., Inc Company Information
Table 83. Pharmicell Co., Inc Introduction and Business Overview
Table 84. Pharmicell Co., Inc Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 85. Pharmicell Co., Inc Autologous Biologics Product Offerings
Table 86. Pharmicell Co., Inc Recent Development
Table 87. Neostem Company Information
Table 88. Neostem Introduction and Business Overview
Table 89. Neostem Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 90. Neostem Autologous Biologics Product Offerings
Table 91. Neostem Recent Development
Table 92. Dendreon Corporation Company Information
Table 93. Dendreon Corporation Introduction and Business Overview
Table 94. Dendreon Corporation Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 95. Dendreon Corporation Autologous Biologics Product Offerings
Table 96. Dendreon Corporation Recent Development
Table 97. Regenexx Company Information
Table 98. Regenexx Introduction and Business Overview
Table 99. Regenexx Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 100. Regenexx Autologous Biologics Product Offerings
Table 101. Regenexx Recent Development
Table 102. Cytori Therapeutics Company Information
Table 103. Cytori Therapeutics Introduction and Business Overview
Table 104. Cytori Therapeutics Autologous Biologics Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 105. Cytori Therapeutics Autologous Biologics Product Offerings
Table 106. Cytori Therapeutics Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Autologous Biologics Downstream Customers
Table 110. Autologous Biologics Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Autologous Biologics Product Picture
Figure 2. Global Autologous Biologics Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Autologous Biologics Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Autologous Biologics Sales Volume (2020-2031) & (Kg)
Figure 5. Global Autologous Biologics Sales Price (2020-2031) & (US$/Kg)
Figure 6. Autologous Biologics Report Years Considered
Figure 7. Global Autologous Biologics Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Autologous Biologics Players Sales Volume Ranking (2024) & (Kg)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Autologous Biologics Revenue in 2024
Figure 10. Autologous Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Adipose Tissue Picture
Figure 12. Plasma Picture
Figure 13. Others Picture
Figure 14. Global Autologous Biologics Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Autologous Biologics Sales Value Market Share by Type, 2024 & 2031
Figure 16. Global Autologous Biologics Sales Volume by Type (2020 VS 2024 VS 2031) & (Kg)
Figure 17. Global Autologous Biologics Sales Volume Market Share by Type, 2024 & 2031
Figure 18. Global Autologous Biologics Price by Type (2020-2031) & (US$/Kg)
Figure 19. Product Picture of Hospitals
Figure 20. Product Picture of Ambulatory Centers
Figure 21. Product Picture of Research Centers
Figure 22. Global Autologous Biologics Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Autologous Biologics Sales Value Market Share by Application, 2024 & 2031
Figure 24. Global Autologous Biologics Sales Volume by Application (2020 VS 2024 VS 2031) & (Kg)
Figure 25. Global Autologous Biologics Sales Volume Market Share by Application, 2024 & 2031
Figure 26. Global Autologous Biologics Price by Application (2020-2031) & (US$/Kg)
Figure 27. North America Autologous Biologics Sales Value (2020-2031) & (US$ Million)
Figure 28. North America Autologous Biologics Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe Autologous Biologics Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe Autologous Biologics Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific Autologous Biologics Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Autologous Biologics Sales Value by Region (%), 2024 VS 2031
Figure 33. South America Autologous Biologics Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America Autologous Biologics Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa Autologous Biologics Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa Autologous Biologics Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions Autologous Biologics Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions Autologous Biologics Sales Volume (%), (2020-2031)
Figure 39. United States Autologous Biologics Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Autologous Biologics Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Autologous Biologics Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe Autologous Biologics Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Autologous Biologics Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Autologous Biologics Sales Value by Application (%), 2024 VS 2031
Figure 45. China Autologous Biologics Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Autologous Biologics Sales Value by Type (%), 2024 VS 2031
Figure 47. China Autologous Biologics Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan Autologous Biologics Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Autologous Biologics Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Autologous Biologics Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea Autologous Biologics Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Autologous Biologics Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Autologous Biologics Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia Autologous Biologics Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Autologous Biologics Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Autologous Biologics Sales Value by Application (%), 2024 VS 2031
Figure 57. India Autologous Biologics Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Autologous Biologics Sales Value by Type (%), 2024 VS 2031
Figure 59. India Autologous Biologics Sales Value by Application (%), 2024 VS 2031
Figure 60. Autologous Biologics Industrial Chain
Figure 61. Autologous Biologics Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Autologous Biologics market?
The top companies in the global Autologous Biologics market are Vericel Corporation、BioTime, Inc.、Pharmicell Co..
Related Reports
Autologous Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Autologous Biologics was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 130
USD 3950.00
(Single User License)
Global Autologous Biologics Market Research Report 2026
The global Autologous Biologics market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 115
USD 2900.00
(Single User License)
Global Autologous Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Autologous Biologics market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 78
USD 4250.00
(Single User License)
Global Autologous Biologics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Autologous Biologics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 131
USD 4900.00
(Single User License)
Global Autologous Biologics Market Research Report 2025
The global market for Autologous Biologics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 83
USD 2900.00
(Single User License)
Autologous Biologics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Autologous Biologics was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 130
USD 3950.00 (Single User License)Global Autologous Biologics Market Research Report 2026
The global Autologous Biologics market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 115
USD 2900.00 (Single User License)Global Autologous Biologics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Autologous Biologics market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 78
USD 4250.00 (Single User License)Global Autologous Biologics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Autologous Biologics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 131
USD 4900.00 (Single User License)Global Autologous Biologics Market Research Report 2025
The global market for Autologous Biologics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 83
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now